Neurofeedback for Mild Cognitive Impairment

Phase-Based Progress Estimates
Mild Cognitive ImpairmentNeurofeedback - Behavioral
50 - 85
All Sexes
What conditions do you have?

Study Summary

This trial is studying a potential treatment for Alzheimer's disease that involves training people to change their brain function.

Eligible Conditions
  • Mild Cognitive Impairment

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: From baseline to 12 weeks of treatment

Week 12
Change in Gamma Band Response
Change in Working Memory accuracy
From baseline to 4weeks post end of study
Durability of Change in Working Memory accuracy
Durability of Gamma Band Response

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Active Treatment
1 of 2
1 of 2

Experimental Treatment

Non-Treatment Group

112 Total Participants · 2 Treatment Groups

Primary Treatment: Neurofeedback · Has Placebo Group · N/A

Active Treatment
Experimental Group · 1 Intervention: Neurofeedback · Intervention Types: Behavioral
ShamComparator Group · 1 Intervention: Placebo · Intervention Types: Other
First Studied
Drug Approval Stage
How many patients have taken this drug
Completed Phase 3

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: from baseline to 12 weeks of treatment

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,028 Previous Clinical Trials
1,805,909 Total Patients Enrolled

Eligibility Criteria

Age 50 - 85 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The ability to live independently is a crucial skill for everyone
I can read and write in English.
able to take part in the decision-making process about whether to agree to a medical procedure, and giving voluntary consent.
Meet certain criteria that suggest that someone has mild cognitive impairment.